Haidar Abdulamir

Dr. Haidar Abdulamir

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Saudi Medical Journal
Verified
Journal Article
Open access
PDF file
HAHaidar Abdulamir
Haidar Abdulamir
OROmar F. Abdul- Rasheed
Omar F. Abdul- Rasheed
EAEmad A. Abdulghani
Emad A. Abdulghani
Serotonin and serotonin transporter levels in autistic children

1 January 2016 in Saudi Medical Journal
Verified
Journal Article
Open access
PDF file
HAHaidar Abdulamir
Haidar Abdulamir
OROmar F. Abdul- Rasheed
Omar F. Abdul- Rasheed
EAEmad A. Abdulghani
Emad A. Abdulghani
Low oxytocin and melatonin levels and their possible role in the diagnosis and prognosis in Iraqi autistic children

1 January 2021 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
PDF file
AAAmeer Aa Aldafaay
Ameer Aa Aldafaay
HAHaidar Abdulamir
Haidar Abdulamir
HAHiba A. Abdulhussain
Hiba A. Abdulhussain
ABAurok S Badry
Aurok S Badry
AAAmeer K Abdulsada
Ameer K Abdulsada
Background: Renal failure is a condition in which the kidneys fail to adequately filter waste products from the blood. Kidney failure is mainly determined by a decrease in glomerular filtration rate. Early recognition could help clinical management, but current indices lack the sufficient predictive value for renal failure. Objective: investigate the status of urine α-amylase in Iraqi patients with chronic renal failure in an attempt to investigate its role in the diagnosis of renal diseases. Methods: A case control study was done on 40 male patients with renal failure who were recruited from the Iraqi Dialysis Center at Baghdad teaching Hospital, Baghdad, Iraq between May and December 2019. The control group comprised of 20 age matched apparently healthy volunteers. Urine samples were obtained from patients and control at 10 A.M and store at (−5C°) until assayed for the evaluation of α-amylase by a colorimetric method. Results: it was demonstrated that there was a significant (p=0.000) decrease in the level of urinary amylase in patients with chronic renal failure in comparison with control. Urinary amylase exhibited AUC values equal to one in patients with chronic renal failure (AUC= 1.00) with an excellent value of accuracy presented as specificity (100%) and sensitivity (100%). Conclusion: Level of urinary α-amylase in chronic renal failure patients was significantly lower than that of controls. It was also demonstrated that the urinary amylase test showed to be an excellent diagnostic and predictive marker in patients with chronic renal failure.

30 August 2022 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
HAHaidar Abdulamir
Haidar Abdulamir
AAAmeer A A Aldafaay
Ameer A A Aldafaay
AAAhmed Hamza Al-Shammari
Ahmed Hamza Al-Shammari
Background: Gaucher disease (GD) is an autosomal recessive hereditary disease. The etiology, pathophysiology, diagnosis, and prognosis of GD in children might all be affected by a variety of biomarkers. The majority of them are linked to abnormalities caused by this lysosomal storage disorder, which is caused by a deficiency of the glucocerebrosidase enzyme that affects numerous organs including the liver, spleen, and bones. Objectives: to investigate the relevance of liver function tests in the assessment of treatment response in children with Gaucher's disease who are undergoing enzyme replacement therapy in a follow-up manner. Methods: A case-control study was performed on 67 children (girls and boys) with GD who were recruited from the Children Welfare Hospital Consultation Clinic, the Gastroenterology and Hepatology Teaching Hospital, and the Central Child's Teaching Hospital. The levels of ALT, AST, total bilirubin (TB), and total protein (TP) were assessed in the samples of 67 Gaucher children, who were classified as recently diagnosed untreated patients (n=9), patients who received ERT for 3-6 months (n=18), 6-12 months (n=20), and patients who received ERT for more than one year (n=20), and compared to twenty newly comparable age-matched controls. The practical part of the study was conducted at research laboratories in the College of Pharmacy, Al-Maaql University and the Department of Pharmacy, Al-Turath University College during the period from December 2020 to March 2021. Results: The results showed that total protein levels in patients were significantly lower than in age-matched control group. The negative significant correlations between the levels of AST, ALT, and TB with the period of receiving treatment and the positive significant correlations between the levels of total protein and the period of receiving treatment indicated that the studied parameters were significantly associated with the period of receiving ERT. The effect of ERT was also indicated by the results of the ANOVA test, which revealed significant variations in the levels of ALT, AST, total bilirubin, and total protein across the patient subgroups. Conclusions: ALT, AST, total bilirubin, and total protein have been shown to have diagnostic significance in newly diagnosed untreated children with a wide range of treatment responses, limiting their utility in treatment monitoring.

24 March 2022 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
YAYasir S J. Alrubaye
Yasir S J. Alrubaye
MMMohammed B. Mohammed
Mohammed B. Mohammed
HAHaidar Abdulamir
Haidar Abdulamir
Breast cancer is responsible for the death of millions of women worldwide every year. It is widespread in the world and Iraq that become a genuine problem for public health. Several clinical, diagnostic and pathological techniques have been introduced to get early detection of breast tumors. The uses of current known tumors markers have many limitations. New technique for diagnosis of breast cancer involve detection of extracellular vesicles (EVs) exosomes and its phosphoproteins as a product of cancer cells which represent a non-invasive liquid biopsy that may replace the invasive surgical method.

1 April 2020 in International Journal of Research in Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
YAYasir Sj. Alrubaye
Yasir Sj. Alrubaye
MAMohammed Bm. Al-Juboori
Mohammed Bm. Al-Juboori
HAHaidar Abdulamir
Haidar Abdulamir
To assess the role of γ-Glutamyltransferase (GGT) and alkaline phosphatase (ALP) in the diagnosis of Gaucher disease (GD) and monitoring the response of liver and bone to the treatment with enzyme replacement therapy (ERT).A case-control study was done on 67 children age range from 3-10 years who had Gaucher disease recruited from the Pediatric Department and Unit of rare disease at Al Imamain Al-Kathemeaain medical city,Gastroenterology and Hepatology Teaching Hospital, Children Welfare Hospital Consultation Clinic and Central Child’s Teaching Hospital. The activity of Alkaline Phosphatase (ALP) and γ- GlutamylTransferase (GGT) enzymes were measured in the samples of 67 Gaucher patients who were categorized as newly diagnosed untreated patients (n=9), patients receiving ERT for 3-5 months (n=18) 6-12 months (n=20) and patients receiving ERT for more than one year (n=20) and compared with twenty age-matched control subjects. The data indicated that the levels of both ALP and GGT in GD patients (216.82 ± 64.51, 35.94 ± 7.11; respectively) were significantly higher than those of controls (163.17 ± 49.34, 28.33 ± 3.36; respectively). Levels of ALP showed to return to levels comparable to those of controls after more than one year of treatment, while GGT levels become comparable to controls’ levels within 6-12 months. Negative significant (p<0.05) correlations were obtained between the levels of ALP and GGT activities with the duration of receiving ERT. Receiver Operating Characteristic (ROC) curve results revealed that GGTshowed a higher area under the curve (AUC), sensitivity, and specificity than ALP activities in all studied groups and subgroups.The possibility of using ALP and GGT as supportive diagnostic markers and as powerful markers for the monitoring of the liver and bone improvement with the administration of ERT.